Sunnyvale, CA and Toronto, Canada 1/29/07—MDS has signed a definitive agreement to purchase Molecular Devices for $615 million in cash, or $35.50 per share, a 49% premium over the January 26 trading price. In the first 12 months, the acquisition is expected to add $190 million in revenues and $45–$50 million in EBITDA (earnings before […]

According to a report by the Statistics Bureau of Japan’s Ministry of Internal Affairs and Communications, total R&D expenditures for Japanese fiscal year (JFY) 2005 (April 1, 2005-March 31, 2006) were ¥17,845.2 billion ($156.5 billion), up 5.4% from JFY 2004. Of this, natural sciences R&D made up ¥16,472.1 billion ($144.5 billion). R&D was 3.53% of […]

Company Announcements NimbleGen Systems named Gregory McGuinness as vice president of International Business. He was previously director of European Business Development for Gene Logic. NimbleGen Systems obtained a license to the “Southern array patents” from Oxford Gene Technology (OGT) and will supply OGT with microarrays for use in its service business. Oxford Gene Technology granted […]